IFNG and cancer: reported a mitochondrial-targeting nanocarrier designed with poly(lactic-co-glycolic acid) (PLGA) and TPP, which significantly increased levels of interferon-gamma (IFN-γ) activated by mitochondrial-targeting immunotherapy in cancer cells.